We found that the inhibition of tumor migration and invasion by ADAMTS18 are associated with deregulation of AKT and NF‐κB signaling pathway, in which AKT pathway was in line with the findings in ADAMTS9, another member of the same subgroup 6. The gene discussed is AKT1; the disease is neoplasm.